While the reduction in the price target from $18 to $17 by Guggenheim could be seen as a negative signal, the maintenance of a Buy rating by analyst Evan Wang suggests continued confidence in Valneva's fundamentals. This mixed signal might lead to a neutral short-term impact on the stock price as investors weigh the lowered price target against the sustained positive outlook.